NIBEC CO., LTD.
Founded in 2004 and listed on KOSDAQ in 2011, NIBEC develops dental tissue regeneration biomaterials and peptide-based biomaterials.
Price
Change
Market cap
Products & technology
- Dental bone graft OCS-BFilling alveolar bone defects and securing bone volume for implant procedures
- Dental bone graft OCS-HFilling alveolar bone defects and securing bone volume for implant procedures
- Tissue regeneration membrane XenoGideUsed with bone graft material to block connective tissue invasion
- Tissue regeneration membrane GuidOssUsed with bone graft material to block connective tissue invasion
- Collagen filler RegenomerExtraction socket filler
- Sheet-form collagen graft RegenoMatrixGuided periodontal tissue regeneration for gingival/periodontal soft tissue reconstruction
- Bone graft-collagen composite OCS-B CollagenComposite bone graft combining high-purity biocollagen with OCS-B bone graft
- Bone graft-collagen composite Equimatrix-CollagenComposite bone graft combining high-purity biocollagen with OCS-H bone graft
- Peptide-fused bone graft OssGen-X15Fusion of bone-regenerating peptide with OCS-B bone graft for bone regeneration in elderly/chronic disease patients and large bone defects
- PeptiCol EZgraftPeriodontal tissue regeneration device composed of osteogenic peptide, photoreactive collagen gel, and collagen sponge
- PeptiCol EZgraft OssBiomaterial combining peptide-fused bone graft OssGen-X15 with collagen regeneration material
- Periodontitis in-vitro diagnostic deviceIn-vitro diagnostic device quantifying salivary cytokine MMP-8 via electrochemical impedance spectroscopy
- Hypersensitivity device SensBlokDelivers nerve-desensitizing agents and blocks stimulus transmission via polymer coating and calcium formation promotion
- Dental conditioner ClinplantRemoves plaque and tartar to prevent periodontal inflammation and peri-implantitis
- Oral health products including dental antibiotic ointment and hypersensitivity treatmentSuppression of periodontal disease-causing bacteria, hypersensitivity treatment, tooth whitening
Regulatory approvals
data.go.kr · openFDA7 Korean MFDS drug approvals · 2015 / 22 Korean MFDS device approvals · 2005–2026 / 1 US FDA 510(k) · 2015
- MFDSDressing, collagen, wound2026-08-04Product approval · Class 3제허 26-596 호
- MFDSBone graft material, animal source or other living things’ source2026-04-30Product approval · Class 4제허 26-325 호
- MFDSProtein analyzer, electronic, plasmonic2025-02-27Product approval · Class 1체외 제신 25-223 호
- MFDSBone graft material, animal source or other living things’ source2024-12-24Product approval · Class 4제허 24-900 호
- MFDSDental polymerization activator- visible light2022-11-04Product approval · Class 1대전 제신 22-1537 호
- MFDSBarrier, intra oral, resorbable2020-04-09Product approval · Class 4제허 20-277 호
- MFDSBarrier, intra oral, resorbable2019-10-18Product approval · Class 4제허 19-659 호
- MFDSagent, dentine, conditioner2018-10-12Product approval · Class 1제신 18-1327 호
- FDARegenomer® Syringe, Regenomer® Plug, Regenomer® Block2015-12-10
- MFDS drug블랑티스에프프로겔15%Revoked2015-07-27Drug · OTC · Notification201505111
- MFDS drug닥터화이티스35%(수출용)2015-06-18Drug · Prescription · Approval201503950
- MFDS drug블랑티스프로겔10%(카바마이드퍼옥사이드)Revoked2015-06-08Drug · OTC · Notification201503646
Show 18 more
- MFDS drug닥터화이티스20%(수출용)2015-06-05Drug · Prescription · Approval201503609
- MFDS drug미노큐어치과용연고(미노사이클린염산염)2015-05-29Drug · Prescription · Notification201503299
- MFDS drug닥터화이티스15%(수출용)2015-05-11Drug · OTC · Notification201502814
- MFDS drug닥터화이티스10%(카바마이드퍼옥사이드)(수출용)2015-04-08Drug · OTC · Notification201501888
- MFDSagent, dentine, conditioner2015-03-27Product approval · Class 1대전 제신 15-32 호
- MFDSagent, dentine, conditioner2015-01-29Product approval · Class 1대전 제신 15-8 호
- MFDSDental syringeRevoked2014-12-22Product approval · Class 1대전 수신 14-93 호
- MFDSBone graft material, composit2014-07-25Product approval · Class 4제허 14-1387 호
- MFDSBone graft material, composit2013-12-13Product approval · Class 4제허 13-2124 호
- MFDSBone graft material, animal source or other living things’ source2011-10-12Product approval · Class 4제허 11-1125 호
- MFDSBone graft material, syntheticRevoked2011-09-21Product approval · Class 4수허 11-1104 호
- MFDSBarrier, intra oral, resorbable2011-08-01Product approval · Class 4제허 11-854 호
- MFDSBarrier, intra oral, resorbable2011-04-12Product approval · Class 4제허 11-403 호
- MFDSagent, dentine, conditioner2009-12-17Product approval · Class 1서울 제신 09-250 호
- MFDSmaterial, dentine, desensitizer2008-08-01Product approval · Class 2제인 08-505 호
- MFDSBone graft material, animal source or other living things’ source2007-06-21Product approval · Class 4제허 07-333 호
- MFDS치주조직재생유도재Revoked2006-03-09Product approval · Class 4제허 06-182 호
- MFDSBone graft material, animal source or other living things’ source2005-09-15Product approval · Class 4제허 05-744 호
Clinical trials
data.go.kr1 MFDS clinical trial authorisations · 2020 (Phase 1 1)
- Phase 1오세오타이드 아세트산염 주2020-02-03
3 trial sites
R&D and key agreements
Source: DART corporate disclosurePepticol 이지그라프트 소재기반 조직재생 유도 의료기기 · 치주조직 재생, 염증 제어 · R&D project via a multi-ministry medical device R&D program combining specific amino acid-containing collagen with anti-inflammatory functional peptides to control the inflammatory environment
Companies approved for the same productsMedical Devices
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
Founded in 1964 and KOSPI-listed in 1991, Shinhung manufactures and distributes dental equipment and materials.
Founded in 2016 and listed on KOSDAQ in 2017, DENTIS manufactures dental implants, medical LED lighting, and dental 3D printers.
KOSDAQ-listed medical device company manufacturing synthetic bioresorbable suture yarn and dental root canal filling materials.
KOSDAQ-listed drug developer whose out-licensed targeted lung cancer therapy has received approval from Korea's MFDS and the US FDA.
KOSDAQ-listed holding company making medical devices and biologics including bone graft rhBMP2 and knee implant TKR.
DIO Corporation, established in 1988 and listed on KOSDAQ in 2000, manufactures and sells dental implants.
Established in 2012 and listed on KOSDAQ in 2018, Osteonic manufactures implants for the CMF, Trauma, Sports Medicine, and Spine categories.
Founded and KOSPI-listed in 2025, Samyang Biopharm develops medical devices, pharmaceuticals, and new drug candidates.
Develops quantitative fluorescence biomarker technology for oral disease diagnostic devices.
KOSDAQ-listed medical device company producing human tissue implants Bella Cell HD and SureFuse.
Founded in 2010 and KOSDAQ-listed in 2019, SCL Science operates medical sealant, bio-logistics, and data platform businesses.
Founded in 2013 and KOSDAQ-listed in 2018, T&R Biofab commercializes 3D bioprinting systems, bioinks, and biodegradable scaffolds.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition